“China’s recovery will largely depend on how the world perceives China right now”
Suresh Pareek, Managing Director, Ideal Cures tells Viveka Roychowdhury that though their US expansion will be on hold currently…
Author
Our field employees are Real Heroes for customer support during COVID-19: Bharat Bhardwaj, Agilent…
Digital connect sessions with customers and virtual coffee talks with employees are few of the ways Agilent Technologies India is…
Giving highest priority to ensure uninterrupted supply of medicines: Sharad Tyagi, Boehringer…
Some difficulties in distribution to stockists but will not face shortages across most locations
Will the industry sell COVID-19 meds at the min production costs?
Will the pharma industry come through? Can the pharma industry resist pressures from investors and shareholders and sacrifice…
“Demand for glass packaging is expected to grow exponentially by next year”
As plastic is being phased out by year-end, pharmaceutical companies will have to rely even more heavily on the old stalwart:…
“Leaders need to embrace uncertainty, explore new opportunities that any crisis brings…
Cactus Communications has been part of the remote work culture for the last 17 years, with global offices in China, Japan, Korea,…
China’s recovery from COVID-19 should not tempt us to take the easy way out again
One silver lining of the COVID-19 infection is that policy decisions have been fast tracked
Coping with COVID-19: AGI glaspac
Dealing with hampered production and lack of input raw materials, AGI glaspac has put in measures to cushion the blow. For…
Book Review: The Perfect Pill
Industry veteran Gauri Chaudhari, co-founder, Brand Innerworld gives an in-the-trenches perspective of brand building in her first…
Lessons from COVID-19
Policymakers will have to balance incentives for the pharma sector to scale up production with strict monitoring on environmental…